Skyhawk Signs its First Oncology Deal with Merck
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 7 (Table of Contents)
Published: 12 Jul-2019
DOI: 10.3833/pdr.v2019.i7.2439 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to secure growth drivers beyond Keytruda® (pembrolizumab), Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS